Stockscreener 앱 받기
0.6016
1.25%
-0.006
전일 마감가:
$0.6076
열려 있는:
$0.5929
하루 거래량:
10,154
Relative Volume:
0.03
시가총액:
$1.09M
수익:
-
순이익/손실:
$-2.86M
주가수익비율:
-0.24
EPS:
-2.5071
순현금흐름:
$-2.57M
1주 성능:
-6.73%
1개월 성능:
-43.93%
6개월 성능:
-48.28%
1년 성능:
-72.22%
1일 변동 폭
$0.5929
$0.607
1주일 범위
$0.5843
$0.6402
52주 변동 폭
$0.5843
$4.1299
Bone Biologics Corp Stock (BBLG) Company Profile
명칭
Bone Biologics Corp
전화
(781) 552-4452
주소
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.6027 | 1.10M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
552.69 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
836.19 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,021.84 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
156.79 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
212.49 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp 주식(BBLG)의 최신 뉴스
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
BBLG Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.43, Though Shares Slip 5.67%Performance Review - vinanet.vn
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeValue ETF - dars.gov.et
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics (BBLG) Dips 3.23% to $0.85 — Shares Approach Key Support at $0.81Money Flow - vinanet.vn
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationSell Signal Alerts - vinanet.vn
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsRetail Driven Moves - dars.gov.et
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - tradingview.com
TradingKey - TradingKey
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates, But Stock DeclinesProfit Cycle Analysis - Vinanet
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Bone Biologics (Nasdaq: BBLG) raises $3M, extends runway to 2027 - Stock Titan
Bone Biologics extends rhNELL-1 shelf life to 29 months - Stock Titan
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - The Manila Times
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline - dars.gov.et
Price to book forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-expected loss fails to lift stockPre-Announcement Alert - vinanet.vn
Form S-3 Bone Biologics Corp For: 17 July - Investing.com India
Form S-3 Bone Biologics Corp For: 17 July By Investing.com - Investing.com Nigeria
Bone Biologics (NASDAQ: BBLG) registers 6.46M warrant shares for resale - Stock Titan
Bone Biologics Corporation Files Form 8-K with SEC: Company Details, Stock Info, and Contact Information (July 2026) - Minichart
Bone Biologics Corp (BBLG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.66%
자본화:
|
볼륨(24시간):